Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-6966

Self Reported Medication for Depression Screening and Follow Up

XMLWordPrintable

    • Icon: EC eCQMs EC eCQMs
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Hide
      Thank you for your inquiry specific to CMS2v13 Preventative Care and Screening: Screening for Depression and Follow-Up Plan. Your scenario describes cases where patients with an active diagnosis of depression, who are currently receiving treatment, may not meet the numerator criteria for appropriate follow-up after a positive depression screen if there are no changes to the current treatment (e.g., a clinician decides to continue a patient’s antidepressant medication and does not order a refill). Please note that this issue is addressed in the eCQM Known Issue EKI-22 (https://oncprojectracking.healthit.gov/support/browse/EKI-22).

      Please follow the current measure logic, as specified, for CMS2v13. For patients that are advised to continue their depression care plan, clinicians can consider mapping to the following codes: SNOMED CT 410234004 (Management of mental health treatment (procedure)) or SNOMED CT 410232000 (Mental health treatment assessment (procedure)). These codes are found in the Follow Up for Adolescent Depression (2.16.840.1.113883.3.526.3.1569) and Follow Up for Adult Depression (2.16.840.1.113883.3.526.3.1568) value sets. For example, if the clinician recommends continuing the patient's self-reported antidepressant medication, then the clinician needs to document this in the EHR and use one of the codes noted above (i.e., EKI-22).
      Show
      Thank you for your inquiry specific to CMS2v13 Preventative Care and Screening: Screening for Depression and Follow-Up Plan. Your scenario describes cases where patients with an active diagnosis of depression, who are currently receiving treatment, may not meet the numerator criteria for appropriate follow-up after a positive depression screen if there are no changes to the current treatment (e.g., a clinician decides to continue a patient’s antidepressant medication and does not order a refill). Please note that this issue is addressed in the eCQM Known Issue EKI-22 ( https://oncprojectracking.healthit.gov/support/browse/EKI-22 ). Please follow the current measure logic, as specified, for CMS2v13. For patients that are advised to continue their depression care plan, clinicians can consider mapping to the following codes: SNOMED CT 410234004 (Management of mental health treatment (procedure)) or SNOMED CT 410232000 (Mental health treatment assessment (procedure)). These codes are found in the Follow Up for Adolescent Depression (2.16.840.1.113883.3.526.3.1569) and Follow Up for Adult Depression (2.16.840.1.113883.3.526.3.1568) value sets. For example, if the clinician recommends continuing the patient's self-reported antidepressant medication, then the clinician needs to document this in the EHR and use one of the codes noted above (i.e., EKI-22 ).
    • CMS0002v13
    • Some patients report already being on antidepressant medications after screening positive for depression screening, but it's unclear if self reported medications should be considered follow up

      For the Preventive Care and Screening: Screening for Depression and Follow-Up Plan CMS2v13 (https://ecqi.healthit.gov/sites/default/files/ecqm/measures/CMS2v13.html) It is unclear how patient self reported medications should or should not be counted. In the below scenario should the patient be in the numerator of the measure. Why or why not?

       

      A 35 year old patient has a qualifying encounter on 3/1/2024 and during the encounter screens positive for depression (assume a standardized depression screening tool is used). The patient self reports they are actively on an antidepressant medication that was prescribed by a different provider at a different organization. This medication also appears in the valueset "Adult Depression Medications" (2.16.840.1.113883.3.526.3.1566).  The provider documents this medication as a patient self reported medication and notes the depression screening follow up is for the patient to continue taking this medication. 

      Assuming the patient does not meet any of the exclusions or exceptions and does not have another qualifying encounter the rest of 2024, should the patient be in the numerator of the measure for calendar year 2024? Why or Why not?

       

      Best,

      Parker

            edave Mathematica EC eCQM Team
            pgarman@wphca.org Parker Garman
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: